| 翻訳と辞書 |
| Spotlight Innovation ： ウィキペディア英語版 |
Spotlight Innovation
Spotlight Innovation Inc. (OTCQB: (STLT )) is a United States pharmaceutical holding company that identifies and acquires early stage pharmaceutical companies that are developing unique intellectual property often in academic settings. The company currently maintains two subsidiaries: Memcine Pharmaceuticals, Inc. and Celtic Biotech Iowa, Inc. Spotlight Innovation Inc. is based in West Des Moines, Iowa and is publicly traded on the OTCQB marketplace under the stock ticker symbol, STLT.〔
==History==
Spotlight Innovation Inc. was founded in 2012 as Spotlight Innovation, LLC. It became its current iteration in December 2013 after a merger with American Exploration Corp. (AEXP), which had been founded in 2006. At the time of the merger, the new entity, Spotlight Innovation Inc., named Cristopher Grunewald the Chief Executive Officer. The Financial Industry Regulatory Authority approved the name change and the merger on December 16, 2013.〔 Spotlight Innovation began trading on the OTCQB marketplace as STLT in January of 2014.
In 2014, Spotlight Innovation founded Celtic Biotech Iowa, Inc., as a subsidiary and entered into a share exchange agreement with Celtic Biotech LTD, an Ireland-based pharmaceutical company developing products for the treatment of cancer and pain. According to the terms of the agreement, Celtic Biotech LTD became a subsidiary of Celtic Biotech Iowa, Inc. and was also granted access to Spotlight Innovation's commercialization and business development services.〔 In April 2015, Celtic Biotech Iowa's first product, a formulation developed to facilitate topical delivery of drugs called EPISORB, was registered with the Food and Drug Administration and incorporated into the Pharmacy Benefit Managers database.〔
In March 2015, Spotlight entered into a purchase agreement with Memcine Pharmaceuticals, Inc., a Coralville, Iowa-based biotech company specializing in vaccine efficacy. Memcine Pharmaceuticals would officially become a Spotlight Innovation subsidiary in June 2015.〔 In April 2015, Spotlight Innovation secured $2.5 million in financing from an unsecured convertible promissory note.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Spotlight Innovation」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|